EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Current insights into apolipoprotein E and the immune response in Alzheimer's disease

Peter Bor-Chian Lin iD, David M Holtzman iD

Immunological Reviews · 2024

DOI: 10.1111/imr.13414 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2024. Verfasst von Peter Bor-Chian Lin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University, St. Louis, Missou…. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoproteins E, Immunity, Innate, Amyloid beta-Peptides. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Tau Consortium, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a progressive neurological disorder and the most common cause of dementia. Genetic analyses identified apolipoprotein E ( APOE ) as the strongest genetic risk for late‐onset AD. Studies have shown that ApoE modulates AD pathogenesis in part by influencing amyloid‐β (Aβ) deposition. However, ApoE also appears to regulate elements of AD via regulation of innate immune response, especially through microglial and astrocyte activation. In model systems, it also regulates changes in T‐cells. This review focuses on the key findings that have advanced our understanding of the role of ApoE in the pathogenesis of AD and the current view of innate immune response regulated by ApoE in AD, while discussing open questions and areas for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseApolipoproteins EImmunity, InnateAmyloid beta-PeptidesMicrogliaHumansAnimalsAstrocytesT-LymphocytesGenetic Predisposition to Disease

Stichwörter der Autor:innen

Alzheimer's diseaseapolipoprotein Eimmune responses

Substanzen

Apolipoproteins EAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University, St. Louis, Missouri, USA.

ORCID-Profile: Peter Bor-Chian Lin, David M Holtzman

Förderung

  • NINDS NIH HHS
  • Tau Consortium
  • NIA NIH HHS
  • JPB Foundation
  • Cure Alzheimer's Fund
  • National Institute on Aging
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Lin, P. B., & Holtzman, D. M. (2024). Current insights into apolipoprotein E and the immune response in Alzheimer's disease. Immunological Reviews. https://doi.org/10.1111/imr.13414

Vancouver

Lin PB, Holtzman DM. Current insights into apolipoprotein E and the immune response in Alzheimer's disease. Immunological Reviews. 2024. doi:10.1111/imr.13414

BibTeX
@article{Lin2024,
  author = {Lin, Peter Bor-Chian and Holtzman, David M},
  title = {Current insights into apolipoprotein E and the immune response in Alzheimer's disease},
  journal = {Immunological Reviews},
  year = {2024},
  doi = {10.1111/imr.13414}
}
Kostenlos starten →